Work

Phase II study of the farnesyl transferase inhibitor tipifarnib plus fulvestrant in postmenopausal patients with hormone receptor-positive breast cancer: New York Cancer Consortium Trial P6205

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.1037

Authors: T. Li, P. Christos, J. A. Sparano, D. L. Hershman, K. O’Brien, S. Hoschander, J. Wright, L. T. Vahdat

Institutions: Montefiore Medical Center, Cornell University, National Cancer Institute, Weill Cornell Medicine, Columbia University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W436992559

Cites:

Cited by: 3

Related to: 10